SpinDiag

company

About

Spindiag develops an easy-to-use, compact, and automated point-of-care system.

  • 51 - 100

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
€15M
Industries
Health Care,Medical,Medical Device
Founded date
Jan 1, 2016
Number Of Employee
51 - 100
Operating Status
Active

Spindiag provides an easy-to-use, compact, and automated point-of-care system for the broad, fast, and affordable detection of pathogens. It's first product is an automated SARS-CoV-2 test. Spindiag one can be operated with an easy to use and routine-compatible workflow by a nurse. Test results are directly transferred into the patient record. The patented centrifugal-microfluidic test system rapidly provides laboratory-grade PCR results directly from standard patient swab samples. SpinDiag works with your standard Copan ESwab® and allows culture confirmation or other lab tests without the necessity to take a second sample. The complete workflow is fully automated and suitable for operation by ward nurses. It features an ultrafast and highly-sensitive polymerase chain reaction (PCR).

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€15M
SpinDiag has raised a total of €15M in funding over 2 rounds. Their latest funding was raised on Oct 17, 2022 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 17, 2022 Debt Financing €15M 1 European Investment Bank Detail

Investors

Number of Lead Investors
Number of Investors
1
1
SpinDiag is funded by 1 investors. European Investment Bank are the most recent investors.
Investor Name Lead Investor Funding Round
European Investment Bank Yes Debt Financing